Intelligent Bio Solutions Stock Buy Hold or Sell Recommendation
| INBS Stock | USD 1.43 0.01 0.69% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Intelligent Bio Solutions is 'Strong Buy'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Intelligent Bio Solutions given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Intelligent Bio Solutions, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Intelligent Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Intelligent and provide practical buy, sell, or hold advice based on investors' constraints. Intelligent Bio Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Intelligent |
Execute Intelligent Bio Buy or Sell Advice
The Intelligent recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Intelligent Bio Solutions. Macroaxis does not own or have any residual interests in Intelligent Bio Solutions or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Intelligent Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Intelligent Bio Trading Alerts and Improvement Suggestions
| Intelligent Bio generated a negative expected return over the last 90 days | |
| Intelligent Bio has high historical volatility and very poor performance | |
| Intelligent Bio may become a speculative penny stock | |
| Intelligent Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 3.11 M. Net Loss for the year was (10.19 M) with profit before overhead, payroll, taxes, and interest of 326.67 K. | |
| Intelligent Bio Solutions currently holds about 8.28 M in cash with (9.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.56. | |
| Intelligent Bio has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Intelligent Bio Solutions Announces 510 Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology |
Intelligent Bio Returns Distribution Density
The distribution of Intelligent Bio's historical returns is an attempt to chart the uncertainty of Intelligent Bio's future price movements. The chart of the probability distribution of Intelligent Bio daily returns describes the distribution of returns around its average expected value. We use Intelligent Bio Solutions price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Intelligent Bio returns is essential to provide solid investment advice for Intelligent Bio.
| Mean Return | -0.29 | Value At Risk | -8.11 | Potential Upside | 9.93 | Standard Deviation | 5.61 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Intelligent Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Intelligent Stock Institutional Investors
The Intelligent Bio's institutional investors refer to entities that pool money to purchase Intelligent Bio's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Hudson Bay Capital Management Lp | 2024-06-30 | 0.0 | Citigroup Inc | 2024-06-30 | 0.0 | Headlands Technologies Llc | 2024-06-30 | 0.0 | Jpmorgan Chase & Co | 2024-06-30 | 0.0 | Virtu Financial Llc | 2024-06-30 | 0.0 | Alyeska Investment Group, L.p. | 2024-09-30 | 206.2 K | Cvi Holdings Llc | 2024-06-30 | 79.8 K | Geode Capital Management, Llc | 2024-09-30 | 22.7 K | Vanguard Group Inc | 2024-09-30 | 15.5 K | Adar1 Capital Management Llc | 2024-09-30 | 5.4 K | Ubs Group Ag | 2024-09-30 | 1.6 K |
Intelligent Bio Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 229.3K | 12.1M | (4.3M) | (6.7M) | 4.8M | 5.0M | |
| Free Cash Flow | (498.6K) | (11.3M) | (3.7M) | (7.9M) | (9.8M) | (10.3M) | |
| Net Income | (3.2M) | (7.1M) | (8.3M) | (10.7M) | (10.2M) | (10.7M) | |
| End Period Cash Flow | 427.3K | 12.6M | 8.2M | 1.5M | 6.3M | 4.7M | |
| Other Non Cash Items | 360.6K | 704.4K | 2.5M | (1.8M) | (122.3K) | (116.2K) | |
| Change To Netincome | 38.1K | 681.4K | 2.5M | 2.2M | 2.5M | 1.6M |
Intelligent Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Intelligent Bio or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Intelligent Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Intelligent stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.34 | |
β | Beta against Dow Jones | 2.01 | |
σ | Overall volatility | 5.67 | |
Ir | Information ratio | -0.06 |
Intelligent Bio Volatility Alert
Intelligent Bio Solutions exhibits very low volatility with skewness of 0.67 and kurtosis of 0.97. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Intelligent Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Intelligent Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Intelligent Bio Fundamentals Vs Peers
Comparing Intelligent Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Intelligent Bio's direct or indirect competition across all of the common fundamentals between Intelligent Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Intelligent Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Intelligent Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Intelligent Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Intelligent Bio to competition |
| Fundamentals | Intelligent Bio | Peer Average |
| Return On Equity | -1.72 | -0.31 |
| Return On Asset | -0.53 | -0.14 |
| Operating Margin | (3.86) % | (5.51) % |
| Current Valuation | 3.09 M | 16.62 B |
| Shares Outstanding | 4.39 M | 571.82 M |
| Shares Owned By Insiders | 3.01 % | 10.09 % |
| Shares Owned By Institutions | 14.38 % | 39.21 % |
| Number Of Shares Shorted | 450.49 K | 4.71 M |
| Price To Book | 1.03 X | 9.51 X |
| Price To Sales | 2.02 X | 11.42 X |
| Revenue | 3.11 M | 9.43 B |
| Gross Profit | 326.67 K | 27.38 B |
| EBITDA | (8.81 M) | 3.9 B |
| Net Income | (10.19 M) | 570.98 M |
| Cash And Equivalents | 8.28 M | 2.7 B |
| Cash Per Share | 0.56 X | 5.01 X |
| Total Debt | 871.44 K | 5.32 B |
| Current Ratio | 2.33 X | 2.16 X |
| Book Value Per Share | 2.41 X | 1.93 K |
| Cash Flow From Operations | (9.57 M) | 971.22 M |
| Short Ratio | 1.25 X | 4.00 X |
| Earnings Per Share | (2.30) X | 3.12 X |
| Target Price | 12.0 | |
| Number Of Employees | 50 | 18.84 K |
| Beta | 4.72 | -0.15 |
| Market Capitalization | 6.14 M | 19.03 B |
| Total Asset | 13.78 M | 29.47 B |
| Retained Earnings | (51.96 M) | 9.33 B |
| Working Capital | 3.08 M | 1.48 B |
| Net Asset | 13.78 M |
Note: Insider Trading [view details]
Intelligent Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Intelligent . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Intelligent Bio Buy or Sell Advice
When is the right time to buy or sell Intelligent Bio Solutions? Buying financial instruments such as Intelligent Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Intelligent Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Toys Thematic Idea Now
Toys
Companies producing and distributing toys and different gaming products for kids. The Toys theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Toys Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.